Adjusting imports of pharmaceuticals and pharmaceutical ingredients into the United States : message from the President of the United States transmitting a notification of action to adjust imports of pharmaceuticals and pharmaceutical ingredients so that such imports will not threaten to impair the national security of the United States, pursuant to 19 U.S.C. 1862(c)(2) ; Public Law 87-794, Sec. 232 (as amended by Public Law 100-418, Sec. 1501(a)(3)) ; (102 Stat. 1258).

Format:

Book

Government document

Author/Creator:

United States. President (2025- : Trump), author.

Trump, Donald, 1946- author.

Contributor:

United States. Congress. House. Committee on Ways and Means, issuing body.

Series:

House document (United States. Congress. House) ; 119-150.

House document / 119th Congress, 2d session ; 119-150

Language:

English

Subjects (All):

Pharmaceutical industry--United States.

Pharmaceutical industry.

Pharmaceutical policy--United States.

Pharmaceutical policy.

Imports--United States.

Imports.

National security--United States.

National security.

Genre:

Legislative materials.

Physical Description:

1 online resource (23 pages).

Place of Publication:

Washington : U.S. Government Publishing Office, 2026.

Notes:

"April 21, 2026."

"Message and accompanying papers referred to the Committee on Ways and Means."

This is a publication issued by the United States federal government or produced with federal funds.

In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).

Description based on online resource, PDF version; title from title page (GovInfo, viewed April 23, 2026).

Other Format:

Print version: United States. President (2025- : Trump), Adjusting imports of pharmaceuticals and pharmaceutical ingredients into the United States

OCLC:

1586977532